Abstract Search

ba0003OP14 | Clinical | ECTS2014

Ten year alendronate use does not adversely affect bone quality compared to 5 years use: a human iliac crest biopsy study

Hassler Norbert , Gamsjaeger Sonja , Hofstetter Birgit , Brozek Wolfgang , Misof Barbara , Roschger Paul , Klaushofer Klaus , Paschalis Eleftherios

see PP359....

0 shares

ba0003pp359 | Osteoporosis: treatment | ECTS2014

Ten year alendronate use does not adversely affect bone quality compared to 5 years use: a human iliac crest biopsy study

Hassler Norbert , Gamsjaeger Sonja , Hofstetter Birgit , Brozek Wolfgang , Misof Barbara , Roschger Paul , Klaushofer Klaus , Paschalis Eleftherios

Bisphosphonates (BPs) including alendronate (ALN) are the most widely prescribed therapy for post-menopausal osteoporosis. Despite their overall excellent safety record and efficacy in reducing fractures, concerns have been expressed lately regarding potential detrimental effects due to prolonged bone turnover reduction, although no definite causeeffect relationship has been established to date. The purpose of the present study was to determine bone material quality by R...

0 shares

Bone Abstracts

Ten year alendronate use does not adversely affect bone quality compared to 5 years use: a human iliac crest biopsy study

Ten year alendronate use does not adversely affect bone quality compared to 5 years use: a human iliac crest biopsy study

BiosciAbstracts